Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities.

Reinhardt A, Stichel D, Schrimpf D, Koelsche C, Wefers AK, Ebrahimi A, Sievers P, Huang K, Casalini MB, Fernández-Klett F, Suwala A, Weller M, Gramatzki D, Felsberg J, Reifenberger G, Becker A, Hans VH, Prinz M, Staszewski O, Acker T, Dohmen H, Hartmann C, Paulus W, Heß K, Brokinkel B, Schittenhelm J, Buslei R, Deckert M, Mawrin C, Hewer E, Pohl U, Jaunmuktane Z, Brandner S, Unterberg A, Hänggi D, Platten M, Pfister SM, Wick W, Herold-Mende C, Korshunov A, Reuss DE, Sahm F, Jones DTW, Capper D, von Deimling A.

Acta Neuropathol Commun. 2019 Oct 28;7(1):163. doi: 10.1186/s40478-019-0801-8.

2.

Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotype.

Koelsche C, Stichel D, Griewank KG, Schrimpf D, Reuss DE, Bewerunge-Hudler M, Vokuhl C, Dinjens WNM, Petersen I, Mittelbronn M, Cuevas-Bourdier A, Buslei R, Pfister SM, Flucke U, Mechtersheimer G, Mentzel T, von Deimling A.

Clin Sarcoma Res. 2019 Feb 14;9:2. doi: 10.1186/s13569-019-0113-6. eCollection 2019.

3.

Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma.

Thurner L, Preuss KD, Bewarder M, Kemele M, Fadle N, Regitz E, Altmeyer S, Schormann C, Poeschel V, Ziepert M, Walter S, Roth P, Weller M, Szczepanowski M, Klapper W, Monoranu C, Rosenwald A, Möller P, Hartmann S, Hansmann ML, Mackensen A, Schäfer H, Schorb E, Illerhaus G, Buslei R, Bohle RM, Stilgenbauer S, Kim YJ, Pfreundschuh M.

Blood. 2018 Dec 27;132(26):2744-2753. doi: 10.1182/blood-2018-03-836932. Epub 2018 Sep 24.

PMID:
30249786
4.

Correction to: DNA methylation-based reclassification of olfactory neuroblastoma.

Capper D, Engel NW, Stichel D, Lechner M, Glöss S, Schmid S, Kölsche C, Schrimpf D, Niesen J, Wefers AK, Jones DTW, Sill M, Weigert O, Ligon KL, Olar A, Koch A, Forster M, Moran S, Tirado OM, Sáinz-Jaspeado M, Mora J, Esteller M, Alonso J, Del Muro XG, Paulus W, Felsberg J, Reifenberger G, Glatzel M, Frank S, Monoranu CM, Lund VJ, von Deimling A, Pfister S, Buslei R, Ribbat-Idel J, Perner S, Gudziol V, Meinhardt M, Schüller U.

Acta Neuropathol. 2018 Sep;136(3):505. doi: 10.1007/s00401-018-1887-y.

PMID:
30094618
5.

Recurrences of Pituitary Adenomas or Second De Novo Tumors: Comparisons with First Tumors.

Saeger W, Müller M, Buslei R, Flitsch J, Fahlbusch R, Buchfelder M, Knappe UJ, Crock PA, Lüdecke DK.

World Neurosurg. 2018 Nov;119:e118-e124. doi: 10.1016/j.wneu.2018.07.056. Epub 2018 Jul 17.

PMID:
30026158
6.

Characterization of the murine orthotopic adamantinomatous craniopharyngioma PDX model by MRI in correlation with histology.

Hölsken A, Schwarz M, Gillmann C, Pfister C, Uder M, Doerfler A, Buchfelder M, Schlaffer S, Fahlbusch R, Buslei R, Bäuerle T.

PLoS One. 2018 May 24;13(5):e0197895. doi: 10.1371/journal.pone.0197895. eCollection 2018.

7.

DNA methylation-based reclassification of olfactory neuroblastoma.

Capper D, Engel NW, Stichel D, Lechner M, Glöss S, Schmid S, Koelsche C, Schrimpf D, Niesen J, Wefers AK, Jones DTW, Sill M, Weigert O, Ligon KL, Olar A, Koch A, Forster M, Moran S, Tirado OM, Sáinz-Jaspeado M, Mora J, Esteller M, Alonso J, Del Muro XG, Paulus W, Felsberg J, Reifenberger G, Glatzel M, Frank S, Monoranu CM, Lund VJ, von Deimling A, Pfister S, Buslei R, Ribbat-Idel J, Perner S, Gudziol V, Meinhardt M, Schüller U.

Acta Neuropathol. 2018 Aug;136(2):255-271. doi: 10.1007/s00401-018-1854-7. Epub 2018 May 5. Erratum in: Acta Neuropathol. 2018 Sep;136(3):505.

PMID:
29730775
8.

Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.

Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE, Koelsche C, Huang K, Wefers AK, Hovestadt V, Sill M, Gramatzki D, Felsberg J, Reifenberger G, Koch A, Thomale UW, Becker A, Hans VH, Prinz M, Staszewski O, Acker T, Dohmen H, Hartmann C, Mueller W, Tuffaha MSA, Paulus W, Heß K, Brokinkel B, Schittenhelm J, Monoranu CM, Kessler AF, Loehr M, Buslei R, Deckert M, Mawrin C, Kohlhof P, Hewer E, Olar A, Rodriguez FJ, Giannini C, NageswaraRao AA, Tabori U, Nunes NM, Weller M, Pohl U, Jaunmuktane Z, Brandner S, Unterberg A, Hänggi D, Platten M, Pfister SM, Wick W, Herold-Mende C, Jones DTW, von Deimling A, Capper D.

Acta Neuropathol. 2018 Aug;136(2):273-291. doi: 10.1007/s00401-018-1837-8. Epub 2018 Mar 21.

PMID:
29564591
9.

Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.

Apps JR, Carreno G, Gonzalez-Meljem JM, Haston S, Guiho R, Cooper JE, Manshaei S, Jani N, Hölsken A, Pettorini B, Beynon RJ, Simpson DM, Fraser HC, Hong Y, Hallang S, Stone TJ, Virasami A, Donson AM, Jones D, Aquilina K, Spoudeas H, Joshi AR, Grundy R, Storer LCD, Korbonits M, Hilton DA, Tossell K, Thavaraj S, Ungless MA, Gil J, Buslei R, Hankinson T, Hargrave D, Goding C, Andoniadou CL, Brogan P, Jacques TS, Williams HJ, Martinez-Barbera JP.

Acta Neuropathol. 2018 May;135(5):757-777. doi: 10.1007/s00401-018-1830-2. Epub 2018 Mar 14.

10.

DNA methylation-based classification of central nervous system tumours.

Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, Stichel D, Olar A, Engel NW, Lindenberg K, Harter PN, Braczynski AK, Plate KH, Dohmen H, Garvalov BK, Coras R, Hölsken A, Hewer E, Bewerunge-Hudler M, Schick M, Fischer R, Beschorner R, Schittenhelm J, Staszewski O, Wani K, Varlet P, Pages M, Temming P, Lohmann D, Selt F, Witt H, Milde T, Witt O, Aronica E, Giangaspero F, Rushing E, Scheurlen W, Geisenberger C, Rodriguez FJ, Becker A, Preusser M, Haberler C, Bjerkvig R, Cryan J, Farrell M, Deckert M, Hench J, Frank S, Serrano J, Kannan K, Tsirigos A, Brück W, Hofer S, Brehmer S, Seiz-Rosenhagen M, Hänggi D, Hans V, Rozsnoki S, Hansford JR, Kohlhof P, Kristensen BW, Lechner M, Lopes B, Mawrin C, Ketter R, Kulozik A, Khatib Z, Heppner F, Koch A, Jouvet A, Keohane C, Mühleisen H, Mueller W, Pohl U, Prinz M, Benner A, Zapatka M, Gottardo NG, Driever PH, Kramm CM, Müller HL, Rutkowski S, von Hoff K, Frühwald MC, Gnekow A, Fleischhack G, Tippelt S, Calaminus G, Monoranu CM, Perry A, Jones C, Jacques TS, Radlwimmer B, Gessi M, Pietsch T, Schramm J, Schackert G, Westphal M, Reifenberger G, Wesseling P, Weller M, Collins VP, Blümcke I, Bendszus M, Debus J, Huang A, Jabado N, Northcott PA, Paulus W, Gajjar A, Robinson GW, Taylor MD, Jaunmuktane Z, Ryzhova M, Platten M, Unterberg A, Wick W, Karajannis MA, Mittelbronn M, Acker T, Hartmann C, Aldape K, Schüller U, Buslei R, Lichter P, Kool M, Herold-Mende C, Ellison DW, Hasselblatt M, Snuderl M, Brandner S, Korshunov A, von Deimling A, Pfister SM.

Nature. 2018 Mar 22;555(7697):469-474. doi: 10.1038/nature26000. Epub 2018 Mar 14.

11.

Oro-dental pathologies in acromegaly.

Kreitschmann-Andermahr I, Kohlmann J, Kleist B, Hirschfelder U, Buslei R, Buchfelder M, Siegel S.

Endocrine. 2018 May;60(2):323-328. doi: 10.1007/s12020-018-1571-y. Epub 2018 Mar 8.

PMID:
29520625
12.

Rathke's Cleft Cyst as Origin of a Pediatric Papillary Craniopharyngioma.

Schlaffer SM, Buchfelder M, Stoehr R, Buslei R, Hölsken A.

Front Genet. 2018 Feb 22;9:49. doi: 10.3389/fgene.2018.00049. eCollection 2018.

13.

Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.

Johann PD, Bens S, Oyen F, Wagener R, Giannini C, Perry A, Raisanen JM, Reis GF, Nobusawa S, Arita K, Felsberg J, Reifenberger G, Agaimy A, Buslei R, Capper D, Pfister SM, Schneppenheim R, Siebert R, Frühwald MC, Paulus W, Kool M, Hasselblatt M.

Am J Surg Pathol. 2018 Apr;42(4):506-511. doi: 10.1097/PAS.0000000000001023.

PMID:
29324471
14.

Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue.

Thimsen V, John N, Buchfelder M, Flitsch J, Fahlbusch R, Stefanits H, Knosp E, Losa M, Buslei R, Hölsken A.

Sci Rep. 2017 Nov 20;7(1):15856. doi: 10.1038/s41598-017-15977-3.

15.

Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine.

Stritzelberger J, Distel L, Buslei R, Fietkau R, Putz F.

Clin Transl Oncol. 2018 Apr;20(4):508-516. doi: 10.1007/s12094-017-1743-x. Epub 2017 Aug 20.

PMID:
28825189
16.

Pituicytoma-An outlook on possible targeted therapies.

Mende KC, Matschke J, Burkhardt T, Saeger W, Buslei R, Buchfelder M, Fahlbusch R, Westphal M, Flitsch J.

CNS Neurosci Ther. 2017 Jul;23(7):620-626. doi: 10.1111/cns.12709. Epub 2017 May 28.

17.

Preclinical transgenic and patient-derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngioma.

Boult JKR, Apps JR, Hölsken A, Hutchinson JC, Carreno G, Danielson LS, Smith LM, Bäuerle T, Buslei R, Buchfelder M, Virasami AK, Koers A, Arthurs OJ, Jacques TS, Chesler L, Martinez-Barbera JP, Robinson SP.

Brain Pathol. 2018 Jul;28(4):475-483. doi: 10.1111/bpa.12525. Epub 2017 May 17.

18.

Models of human adamantinomatous craniopharyngioma tissue: Steps toward an effective adjuvant treatment.

Hölsken A, Buslei R.

Brain Pathol. 2017 May;27(3):358-363. doi: 10.1111/bpa.12499.

PMID:
28414888
19.

Presence of headache and headache types in patients with tumors of the sellar region-can surgery solve the problem? Results of a prospective single center study.

Siegel S, Weber Carneiro R, Buchfelder M, Kleist B, Grzywotz A, Buslei R, Bingel U, Brabant G, Schenk T, Kreitschmann-Andermahr I.

Endocrine. 2017 May;56(2):325-335. doi: 10.1007/s12020-017-1266-9. Epub 2017 Feb 27.

PMID:
28243973
20.

Trigemino-autonomic headache and Horner syndrome as a first sign of granulomatous hypophysitis.

Motte J, Kreitschmann-Andermahr I, Fisse AL, Börnke C, Schroeder C, Pitarokoili K, Müller O, Lukas C, van de Nes J, Buslei R, Gold R, Ayzenberg I.

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 14;4(3):e332. doi: 10.1212/NXI.0000000000000332. eCollection 2017 May.

21.

Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.

Stache C, Bils C, Fahlbusch R, Flitsch J, Buchfelder M, Stefanits H, Czech T, Gaipl U, Frey B, Buslei R, Hölsken A.

Neurosurg Focus. 2016 Dec;41(6):E14.

PMID:
27903123
22.

IgG4-related hypophysitis is highly prevalent among cases of histologically confirmed hypophysitis.

Bernreuther C, Illies C, Flitsch J, Buchfelder M, Buslei R, Glatzel M, Saeger W.

Brain Pathol. 2017 Nov;27(6):839-845. doi: 10.1111/bpa.12459. Epub 2017 Jan 11.

PMID:
27864854
23.

Novel technique for high-precision stereotactic irradiation of mouse brains.

Hartmann J, Wölfelschneider J, Stache C, Buslei R, Derer A, Schwarz M, Bäuerle T, Fietkau R, Gaipl US, Bert C, Hölsken A, Frey B.

Strahlenther Onkol. 2016 Nov;192(11):806-814. Epub 2016 Jul 11.

PMID:
27402389
24.

PREDICTORS OF QUALITY OF LIFE IN 165 PATIENTS WITH ACROMEGALY: RESULTS FROM A SINGLE-CENTER STUDY.

Kreitschmann-Andermahr I, Buchfelder M, Kleist B, Kohlmann J, Menzel C, Buslei R, Kołtowska-Häggsträm M, Strasburger C, Siegel S.

Endocr Pract. 2017 Jan;23(1):79-88. doi: 10.4158/EP161373.OR. Epub 2016 Oct 17.

PMID:
27749131
25.

Immunoprofiling of glial tumours of the neurohypophysis suggests a common pituicytic origin of neoplastic cells.

Hagel C, Buslei R, Buchfelder M, Fahlbusch R, Bergmann M, Giese A, Flitsch J, Lüdecke DK, Glatzel M, Saeger W.

Pituitary. 2017 Apr;20(2):211-217. doi: 10.1007/s11102-016-0762-x.

PMID:
27744503
26.

Hidden association of Cowden syndrome, PTEN mutation and meningioma frequency.

Yakubov E, Ghoochani A, Buslei R, Buchfelder M, Eyüpoglu IY, Savaskan N.

Oncoscience. 2016 Jun 30;3(5-6):149-55. doi: 10.18632/oncoscience.305. eCollection 2016. Review.

27.

EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cysts.

Thimsen V, Hölsken A, Buchfelder M, Flitsch J, Fahlbusch R, Stefanits H, Losa M, Jones DT, Buslei R.

Sci Rep. 2016 Jul 19;6:29731. doi: 10.1038/srep29731.

28.

Diffuse Encephalopathy Associated with Isolated Cerebral Langerhans Cell Histiocytosis.

Rompel O, Buslei R, Hammon M, Dörr HG, Chada M, Nikkhah G, Uder M, Trollmann R.

Pediatr Neurol. 2016 Sep;62:62-5. doi: 10.1016/j.pediatrneurol.2016.05.006. Epub 2016 May 11.

PMID:
27426422
29.

Hedgehog signaling activation induces stem cell proliferation and hormone release in the adult pituitary gland.

Pyczek J, Buslei R, Schult D, Hölsken A, Buchfelder M, Heß I, Hahn H, Uhmann A.

Sci Rep. 2016 Apr 25;6:24928. doi: 10.1038/srep24928.

30.

Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma.

Eyüpoglu IY, Hore N, Merkel A, Buslei R, Buchfelder M, Savaskan N.

Oncotarget. 2016 May 3;7(18):25755-68. doi: 10.18632/oncotarget.8367.

31.

Erratum: Histological criteria for atypical pituitary adenomas--data from the German pituitary adenoma registry suggests modifications.

Miermeister CP, Petersenn S, Buchfelder M, Fahlbusch R, Lüdecke DK, Hölsken A, Bergmann M, Knappe UJ, Hans VH, Flitsch J, Saeger W, Buslei R.

Acta Neuropathol Commun. 2016 Feb 29;4:21. doi: 10.1186/s40478-016-0290-y.

32.

Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles.

Hölsken A, Sill M, Merkle J, Schweizer L, Buchfelder M, Flitsch J, Fahlbusch R, Metzler M, Kool M, Pfister SM, von Deimling A, Capper D, Jones DT, Buslei R.

Acta Neuropathol Commun. 2016 Feb 29;4:20. doi: 10.1186/s40478-016-0287-6.

33.

Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification.

Saeger W, Petersenn S, Schöfl C, Knappe UJ, Theodoropoulou M, Buslei R, Honegger J.

Endocr Pathol. 2016 Jun;27(2):115-22. doi: 10.1007/s12022-016-9419-6. Review.

PMID:
26874696
34.

Clinical Impact of the Current WHO Classification of Pituitary Adenomas.

Saeger W, Honegger J, Theodoropoulou M, Knappe UJ, Schöfl C, Petersenn S, Buslei R.

Endocr Pathol. 2016 Jun;27(2):104-14. doi: 10.1007/s12022-016-9418-7. Review.

PMID:
26860936
35.

Erratum to: Primary glioblastoma multiforme tumors and recurrence: comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.

Muth C, Rubner Y, Semrau S, Rühle PF, Frey B, Strnad A, Buslei R, Fietkau R, Gaipl US.

Strahlenther Onkol. 2016 Mar;192(3):156. doi: 10.1007/s00066-016-0942-7. No abstract available.

PMID:
26809739
36.

Diagnosis and management of acromegaly: the patient's perspective.

Kreitschmann-Andermahr I, Siegel S, Kleist B, Kohlmann J, Starz D, Buslei R, Koltowska-Häggström M, Strasburger CJ, Buchfelder M.

Pituitary. 2016 Jun;19(3):268-76. doi: 10.1007/s11102-015-0702-1.

PMID:
26742496
37.

Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.

Muth C, Rubner Y, Semrau S, Rühle PF, Frey B, Strnad A, Buslei R, Fietkau R, Gaipl US.

Strahlenther Onkol. 2016 Mar;192(3):146-55. doi: 10.1007/s00066-015-0926-z. Epub 2015 Dec 8. Erratum in: Strahlenther Onkol. 2016 Mar;192(3):156.

PMID:
26646311
38.

EZH2 is highly expressed in pituitary adenomas and associated with proliferation.

Schult D, Hölsken A, Siegel S, Buchfelder M, Fahlbusch R, Kreitschmann-Andermahr I, Buslei R.

Sci Rep. 2015 Nov 23;5:16965. doi: 10.1038/srep16965.

39.

Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications.

Miermeister CP, Petersenn S, Buchfelder M, Fahlbusch R, Lüdecke DK, Hölsken A, Bergmann M, Knappe HU, Hans VH, Flitsch J, Saeger W, Buslei R.

Acta Neuropathol Commun. 2015 Aug 19;3:50. doi: 10.1186/s40478-015-0229-8. Erratum in: Acta Neuropathol Commun. 2016;4(1):21.

40.

[Rheumatoid vasculitis of the central nervous system].

Lee DH, Blinzler C, Stöckl T, Engelhorn T, Buslei R, Schwab S, Linker RA.

Nervenarzt. 2015 Feb;86(2):202-4. doi: 10.1007/s00115-014-4238-9. German. No abstract available.

PMID:
25637081
41.

Intraoperative vascular DIVA surgery reveals angiogenic hotspots in tumor zones of malignant gliomas.

Eyüpoglu IY, Hore N, Fan Z, Buslei R, Merkel A, Buchfelder M, Savaskan NE.

Sci Rep. 2015 Jan 22;5:7958. doi: 10.1038/srep07958.

42.

Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models.

Martinez-Barbera JP, Buslei R.

J Pediatr Endocrinol Metab. 2015 Jan;28(1-2):7-17. doi: 10.1515/jpem-2014-0442. Review.

PMID:
25503464
43.

BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts.

Schweizer L, Capper D, Hölsken A, Fahlbusch R, Flitsch J, Buchfelder M, Herold-Mende C, von Deimling A, Buslei R.

Neuropathol Appl Neurobiol. 2015 Oct;41(6):733-42. doi: 10.1111/nan.12201. Epub 2015 May 2.

PMID:
25442675
44.

Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles.

Koelsche C, Hovestadt V, Jones DT, Capper D, Sturm D, Sahm F, Schrimpf D, Adeberg S, Böhmer K, Hagenlocher C, Mechtersheimer G, Kohlhof P, Mühleisen H, Beschorner R, Hartmann C, Braczynski AK, Mittelbronn M, Buslei R, Becker A, Grote A, Urbach H, Staszewski O, Prinz M, Hewer E, Pfister SM, von Deimling A, Reuss DE.

Brain Pathol. 2015 Mar;25(2):202-8. doi: 10.1111/bpa.12228. Epub 2014 Dec 15.

PMID:
25399693
45.

Expression pattern of neuronal intermediate filament α-internexin in anterior pituitary gland and related tumors.

Schult D, Hölsken A, Buchfelder M, Schlaffer SM, Siegel S, Kreitschmann-Andermahr I, Fahlbusch R, Buslei R.

Pituitary. 2015 Aug;18(4):465-73. doi: 10.1007/s11102-014-0597-2.

PMID:
25236435
46.

The Ca2+ sensor protein swiprosin-1/EFhd2 is present in neurites and involved in kinesin-mediated transport in neurons.

Purohit P, Perez-Branguli F, Prots I, Borger E, Gunn-Moore F, Welzel O, Loy K, Wenzel EM, Grömer TW, Brachs S, Holzer M, Buslei R, Fritsch K, Regensburger M, Böhm KJ, Winner B, Mielenz D.

PLoS One. 2014 Aug 18;9(8):e103976. doi: 10.1371/journal.pone.0103976. eCollection 2014.

47.

Insights into the infiltrative behavior of adamantinomatous craniopharyngioma in a new xenotransplant mouse model.

Stache C, Hölsken A, Schlaffer SM, Hess A, Metzler M, Frey B, Fahlbusch R, Flitsch J, Buchfelder M, Buslei R.

Brain Pathol. 2015 Jan;25(1):1-10. doi: 10.1111/bpa.12148. Epub 2014 May 19.

PMID:
24716541
48.

Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines.

Rubner Y, Muth C, Strnad A, Derer A, Sieber R, Buslei R, Frey B, Fietkau R, Gaipl US.

Radiat Oncol. 2014 Mar 30;9(1):89. doi: 10.1186/1748-717X-9-89.

49.

Activation and regulation of endogenous retroviral genes in the human pituitary gland and related endocrine tumours.

Buslei R, Strissel PL, Henke C, Schey R, Lang N, Ruebner M, Stolt CC, Fabry B, Buchfelder M, Strick R.

Neuropathol Appl Neurobiol. 2015 Feb;41(2):180-200. doi: 10.1111/nan.12136.

PMID:
24635849
50.

Comparative study of soft tissue perineurioma and meningioma using a five-marker immunohistochemical panel.

Agaimy A, Buslei R, Coras R, Rubin BP, Mentzel T.

Histopathology. 2014 Jul;65(1):60-70. doi: 10.1111/his.12366. Epub 2014 Feb 24.

PMID:
24393170

Supplemental Content

Loading ...
Support Center